IREN
IREN Limited
There isn't enough reported data to score IREN yet.
NECB
Northeast Community Bancorp, Inc.
NECB's fundamentals are mixed, but it looks expensive: trading at 9.6x earnings, above its usual 7.5x. Analysts expect strong earnings growth.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
NECB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
NECB's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like NECB.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
NECB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.1x | $18.52 | -36% |
| Forward | 7.4x | $29.07 | — |
| Fair | 7.5x | $22.77 | -22% |
| Current | 9.6x | $29.07 | — |
| Expensive | 13x | $39.16 | +35% |
Historical ranges are pointers, not guarantees.
NECB's PE is in its expensive range at 9.6x. If earnings grow as analysts expect, today's price would be 7.4x next year's earnings, in its fair range.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
NECB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
NECB has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
NECB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.94 | +30% |
| Q3 2026 | $3.03 | -5.6% |
| Q2 2026 | $3.11 | -5.5% |
| Q1 2026 | $3.21 | -6.7% |
| Q4 2025 | $3.25 | -7.7% |
| Q3 2025 | $3.21 | -15% |
| Q2 2025 | $3.29 | -9.4% |
| Q1 2025 | $3.44 | +0.9% |
| Q4 2024 | $3.52 | +6% |
NECB has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the edge over NECB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
NECB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $26.1M | -3.2% |
| Q2 2026 | $25.3M | -2.5% |
| Q1 2026 | $24.9M | -2.2% |
| Q4 2025 | $26.4M | +3.9% |
| Q3 2025 | $27M | -2.5% |
| Q2 2025 | $25.9M | -3.8% |
| Q1 2025 | $25.5M | -0.2% |
| Q4 2024 | $25.4M | -4.3% |
NECB's revenue grew through 2023 and has held roughly level since: $26M last quarter, down 3.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 58% | -3.5 points |
| Q2 2026 | 55% | -4.9 points |
| Q1 2026 | 56% | -1.1 points |
| Q4 2025 | 59% | +2 points |
| Q3 2025 | 62% | -2 points |
| Q2 2025 | 59% | -6.1 points |
| Q1 2025 | 57% | -5.3 points |
| Q4 2024 | 57% | -7.5 points |
NECB has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
NECB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11M | -19% |
| Q2 2026 | $12.7M | -15% |
| Q1 2026 | $10.3M | -2.1% |
| Q4 2025 | $11.8M | +17% |
| Q3 2025 | $13.6M | -4.5% |
| Q2 2025 | $14.9M | +35% |
| Q1 2025 | $10.6M | -18% |
| Q4 2024 | $10.1M | -14% |
NECB has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
NECB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +28K shares |
| 1 year | -0.5% | -66K shares |
| 3 years | -8.5% | -1.3M shares |
| 5 years | -17% | -2.8M shares |
NECB has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $168,000 |
| Q2 2026 | $1.1M |
| Q1 2026 | $3.6M |
| Q4 2025 | $1.4M |
| Q4 2024 | $726,000 |
| Q3 2024 | — |
| Q2 2024 | $1.2M |
| Q1 2024 | $1.3M |
NECB spent $6M buying back its own shares over the past year.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
NECB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.9x | Healthy |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.2x | Healthy |
| Q1 2025 | -1.4x | Net Cash |
| Q3 2024 | -1.3x | Net Cash |
| Q2 2024 | -1.0x | Net Cash |
NECB has the edge over IREN on leverage, with a lower net debt burden relative to earnings.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
NECB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.8 | Neutral |
| Stochastic | 76.8 | Neutral |
NECB's weekly RSI is 70 (neutral) and its Stochastic is 77 (neutral).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
NECB PE vs Financial Services Sector
| Metric | NECB | Sector median | Relative |
|---|---|---|---|
| PE | 9.6x | 13x | 26% below |
| PE % | 69 | 63 | 6 pts above |
NECB is trading at 9.6x earnings, a 26% discount to the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
NECB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.9 | 4.4% above |
| 20 week MA | $27.2 | 6.8% above |
| 50 week MA | $25.3 | 15% above |
| 100 week MA | $23.9 | 22% above |
| 200 week MA | $20.8 | 40% above |
NECB has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
NECB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.80 | $10.3 | +17% |
| 2021 | $10.3 | $11.2 | +8.8% |
| 2022 | $11.2 | $15.0 | +35% |
| 2023 | $15.0 | $17.7 | +18% |
| 2024 | $17.7 | $24.8 | +40% |
| 2025 | $24.8 | $23.0 | -7.3% |
| 2026 YTD | $23.0 | $29.1 | +27% |
NECB has the edge over IREN on returns for 2026, with the stronger performance.